Definitive Healthcare (NASDAQ:DH) Releases FY 2024 Earnings Guidance

Definitive Healthcare (NASDAQ:DH) issued an update on its FY 2024 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 0.360-0.380 for the period, compared to the consensus earnings per share estimate of 0.380. The company issued revenue guidance of $255.0 million-$261.0 million, compared to the consensus revenue estimate of $266.3 million. Definitive Healthcare also updated its Q2 2024 guidance to 0.080-0.090 EPS.

Analyst Ratings Changes

A number of research firms have commented on DH. Canaccord Genuity Group decreased their price objective on shares of Definitive Healthcare from $10.00 to $8.00 and set a hold rating for the company in a report on Wednesday. Morgan Stanley cut Definitive Healthcare from an overweight rating to an equal weight rating and cut their price target for the company from $11.50 to $9.00 in a report on Wednesday. Needham & Company LLC reissued a hold rating on shares of Definitive Healthcare in a report on Wednesday. Barclays decreased their price target on shares of Definitive Healthcare from $11.00 to $7.00 and set an equal weight rating on the stock in a research note on Thursday. Finally, Deutsche Bank Aktiengesellschaft cut their target price on shares of Definitive Healthcare from $10.00 to $7.00 and set a hold rating on the stock in a report on Thursday. Nine research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, Definitive Healthcare currently has an average rating of Hold and a consensus price target of $9.94.

Definitive Healthcare Trading Up 2.3 %

DH traded up $0.12 on Friday, hitting $5.29. The company had a trading volume of 2,283,341 shares, compared to its average volume of 661,623. Definitive Healthcare has a 1 year low of $4.38 and a 1 year high of $12.45. The firm has a market cap of $623.11 million, a P/E ratio of -2.90, a PEG ratio of 6.12 and a beta of 1.41. The company has a current ratio of 2.31, a quick ratio of 2.31 and a debt-to-equity ratio of 0.20. The company’s fifty day moving average price is $7.61 and its 200 day moving average price is $8.27.

Definitive Healthcare (NASDAQ:DH) last released its quarterly earnings results on Wednesday, February 28th. The company reported ($0.01) EPS for the quarter, missing the consensus estimate of $0.01 by ($0.02). Definitive Healthcare had a positive return on equity of 0.43% and a negative net margin of 80.40%. The company had revenue of $65.93 million for the quarter, compared to analysts’ expectations of $66.01 million. As a group, equities analysts expect that Definitive Healthcare will post 0.11 earnings per share for the current year.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.